Clinical Trials Browser

Phase 3 × Esophageal Neoplasms × irinotecan sucrosofate × Clear all

NCT06501664 2024-07-15

Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC

Phase 3 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms